Growth Metrics

RxSight (RXST) Net Margin (2020 - 2026)

RxSight posted quarterly Net Margin of 51.42% for Q1 2026, down 2980.0% year-on-year from 1.79% in Q1 2025, and down 83.19% on a QoQ basis from 28.07% in Q4 2025.

RxSight (RXST) has 7 years of Net Margin data on file, last reported at 51.42% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 2980.0% year-over-year to 51.42%; the trailing twelve-month figure through Mar 2026 stood at 36.59% (down 3717.0% YoY), and the FY2025 full-year result was 28.96%, down 2892.0% from the prior year.
  • Net Margin for Q1 2026 stood at 51.42%, down from 28.07% in the prior quarter.
  • Across five years, Net Margin topped out at 317.88% in Q4 2022 and bottomed at 196.78% in Q1 2022.
  • The 5-year median for Net Margin is 32.35% (2025), against an average of 23.57%.
  • The widest annual swing landed in 2022, when Net Margin soared 50461 bps; it then tumbled 17997 bps in 2023.
  • A 5-year view of Net Margin shows it stood at 317.88% in 2022, then tumbled by 57 bps to 137.9% in 2023, then plunged by 61 bps to 53.38% in 2024, then plunged by 153 bps to 28.07% in 2025, then sank by 83 bps to 51.42% in 2026.
  • The last three Net Margin figures came in at 51.42% (Q1 2026), 28.07% (Q4 2025), and 32.35% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.65%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.38%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 12.75%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 8.01%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 RxSight 215.82 Mn -2.06 Mn 23.50 Mn -51.42%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -51.42%
Dec 31, 2025 -28.07%
Sep 30, 2025 -32.35%
Jun 30, 2025 -35.04%
Mar 31, 2025 -21.61%
Dec 31, 2024 53.38%
Sep 30, 2024 -17.95%
Jun 30, 2024 -17.42%
Mar 31, 2024 -30.83%
Dec 31, 2023 137.90%
Sep 30, 2023 -55.93%
Jun 30, 2023 -66.33%
Mar 31, 2023 -75.54%
Dec 31, 2022 317.88%
Sep 30, 2022 -133.32%
Jun 30, 2022 -147.29%
Mar 31, 2022 -196.78%
Dec 31, 2021 -186.73%
Sep 30, 2021 -219.03%
Jun 30, 2021 -275.21%
Mar 31, 2021 -195.32%
Dec 31, 2020 -35.89%
Sep 30, 2020 141.49%
Jun 30, 2020 -627.46%